SCM
RXDX

Suvretta Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Suvretta Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-480,480
Closed -$11.4M – 120
2021
Q3 		$11.4M Sell
480,480
-145,145
-23% -$3.44M 0.19% 64
2021
Q2 		$15.4M Buy
625,625
+47,091
+8% +$1.16M 0.23% 65
2021
Q1 		$10.6M Buy
+578,534
New +$10.6M 0.16% 73